{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:03:18Z","timestamp":1775217798099,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12328-026-02281-9","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T11:42:34Z","timestamp":1771242154000},"page":"406-412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gastrointestinal-localized polymorphic post-transplant lymphoproliferative disorder following kidney transplantation after allogeneic hematopoietic stem cell transplantation: a rare case report"],"prefix":"10.1007","volume":"19","author":[{"given":"Yoshiki","family":"Morihisa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9476-466X","authenticated-orcid":false,"given":"Satoko","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Uyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanari","family":"Minoshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Yabuuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"2281_CR1","doi-asserted-by":"publisher","first-page":"15088","DOI":"10.1038\/nrdp.2015.88","volume":"2","author":"VR Dharnidharka","year":"2016","unstructured":"Dharnidharka VR, Webster AC, Martinez OM, Preiksaitis JK, Leblond V, Choquet S. Post-transplant lymphoproliferative disorders. Nat Rev Dis Primers. 2016;2:15088. https:\/\/doi.org\/10.1038\/nrdp.2015.88.","journal-title":"Nat Rev Dis Primers"},{"key":"2281_CR2","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/NEJMra1702693","volume":"378","author":"D Dierickx","year":"2018","unstructured":"Dierickx D, Habermann TM. Post-Transplantation lymphoproliferative disorders in adults. N Engl J Med. 2018;378:549\u201362. https:\/\/doi.org\/10.1056\/NEJMra1702693.","journal-title":"N Engl J Med"},{"key":"2281_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/ajt.12004","volume":"13","author":"M Green","year":"2013","unstructured":"Green M, Michaels MG. Epstein-Barr virus infection and posttransplant lymphoproliferative disorder. Am J Transpl. 2013;13:41\u201354. https:\/\/doi.org\/10.1111\/ajt.12004. quiz 54.","journal-title":"Am J Transpl"},{"key":"2281_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1080\/10428194.2018.1474462","volume":"60","author":"S Romero","year":"2019","unstructured":"Romero S, Montoro J, Guinot M, Almenar L, Andreu R, Balaguer A, et al. Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation. Leuk Lymphoma. 2019;60:142\u201350. https:\/\/doi.org\/10.1080\/10428194.2018.1474462.","journal-title":"Leuk Lymphoma"},{"key":"2281_CR5","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the world health organization classification of lymphoid neoplasms. Blood. 2016;127:2375\u201390. https:\/\/doi.org\/10.1182\/blood-2016-01-643569.","journal-title":"Blood"},{"key":"2281_CR6","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36:1720\u201348. https:\/\/doi.org\/10.1038\/s41375-022-01620-2.","journal-title":"Leukemia"},{"key":"2281_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","volume":"4","author":"G Opelz","year":"2004","unstructured":"Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transpl. 2004;4:222\u201330. https:\/\/doi.org\/10.1046\/j.1600-6143.2003.00325.x.","journal-title":"Am J Transpl"},{"key":"2281_CR8","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.3109\/10428194.2013.780655","volume":"54","author":"D Dierickx","year":"2013","unstructured":"Dierickx D, Tousseyn T, Sagaert X, Fieuws S, Wlodarska I, Morscio J, et al. Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors. Leuk Lymphoma. 2013;54:2433\u201340. https:\/\/doi.org\/10.3109\/10428194.2013.780655.","journal-title":"Leuk Lymphoma"},{"key":"2281_CR9","doi-asserted-by":"publisher","first-page":"151503","DOI":"10.1016\/j.semnephrol.2024.151503","volume":"44","author":"VR Dharnidharka","year":"2024","unstructured":"Dharnidharka VR, Ruzinova MB, Marks LJ. Post-Transplant lymphoproliferative disorders. Semin Nephrol. 2024;44:151503. https:\/\/doi.org\/10.1016\/j.semnephrol.2024.151503.","journal-title":"Semin Nephrol"},{"key":"2281_CR10","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1182\/blood-2015-05-615872","volume":"126","author":"D Dierickx","year":"2015","unstructured":"Dierickx D, Tousseyn T, Gheysens O. How I treat posttransplant lymphoproliferative disorders. Blood. 2015;126:2274\u201383. https:\/\/doi.org\/10.1182\/blood-2015-05-615872.","journal-title":"Blood"},{"key":"2281_CR11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/bjh.15263","volume":"182","author":"CB DeStefano","year":"2018","unstructured":"DeStefano CB, Desai SH, Shenoy AG, Catlett JP. Management of post-transplant lymphoproliferative disorders. Br J Haematol. 2018;182:330\u201343. https:\/\/doi.org\/10.1111\/bjh.15263.","journal-title":"Br J Haematol"},{"key":"2281_CR12","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1182\/blood.V94.7.2208.419k21_2208_2216","volume":"94","author":"RE Curtis","year":"1999","unstructured":"Curtis RE, Travis LB, Rowlings PA, Soci\u00e9 G, Kingma DW, Banks PM, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: A Multi-Institutional study. Blood. 1999;94:2208\u201316. https:\/\/doi.org\/10.1182\/blood.V94.7.2208.419k21_2208_2216.","journal-title":"Blood"},{"key":"2281_CR13","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1182\/blood-2008-09-178046","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren O, Gilbert ES, Rizzo JD, Soci\u00e9 G, Banks PM, Sobocinski KA, et al. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood. 2009;113:4992\u20135001. https:\/\/doi.org\/10.1182\/blood-2008-09-178046.","journal-title":"Blood"},{"key":"2281_CR14","doi-asserted-by":"publisher","first-page":"7542","DOI":"10.3390\/jcm11247542","volume":"11","author":"M Clerico","year":"2022","unstructured":"Clerico M, Dogliotti I, Aroldi A, Consoli C, Giaccone L, Bruno B, et al. Post-Transplant lymphoproliferative disease (PTLD) after allogeneic hematopoietic stem cell transplantation: biology and treatment options. J Clin Med. 2022;11:7542. https:\/\/doi.org\/10.3390\/jcm11247542.","journal-title":"J Clin Med"},{"key":"2281_CR15","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/bmt.2014.28","volume":"49","author":"Y Arai","year":"2014","unstructured":"Arai Y, Yamashita K, Mizugishi K, Kondo T, Kitano T, Hishizawa M, et al. Risk factors for hypogammaglobulinemia after allo-SCT. Bone Marrow Transpl. 2014;49:859\u201361. https:\/\/doi.org\/10.1038\/bmt.2014.28.","journal-title":"Bone Marrow Transpl"},{"key":"2281_CR16","doi-asserted-by":"publisher","first-page":"773853","DOI":"10.3389\/fimmu.2021.773853","volume":"12","author":"F Luterbacher","year":"2021","unstructured":"Luterbacher F, Bernard F, Baleydier F, Ranza E, Jandus P, Blanchard-Rohner G. Case report: persistent hypogammaglobulinemia more than 10 years after rituximab given Post-HSCT. Front Immunol. 2021;12:773853. https:\/\/doi.org\/10.3389\/fimmu.2021.773853.","journal-title":"Front Immunol"},{"key":"2281_CR17","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3389\/fimmu.2016.00507","volume":"7","author":"J Ogonek","year":"2016","unstructured":"Ogonek J, Kralj Juric M, Ghimire S, Varanasi PR, Holler E, Greinix H, et al. Immune reconstitution after allogeneic hematopoietic stem cell transplantation. Front Immunol. 2016;7:507. https:\/\/doi.org\/10.3389\/fimmu.2016.00507.","journal-title":"Front Immunol"},{"key":"2281_CR18","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1600-6143.2005.00776.x","volume":"5","author":"J Trofe","year":"2005","unstructured":"Trofe J, Buell JF, Beebe TM, Hanaway MJ, First MR, Alloway RR, et al. Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn international transplant tumor registry experience. Am J Transpl. 2005;5:775\u201380. https:\/\/doi.org\/10.1111\/j.1600-6143.2005.00776.x.","journal-title":"Am J Transpl"},{"key":"2281_CR19","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1111\/j.1600-6143.2006.01540.x","volume":"6","author":"S Caillard","year":"2006","unstructured":"Caillard S, Lelong C, Pessione F, Moulin B, French PTLD, Working Group. Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French registry. Am J Transpl. 2006;6:2735\u201342. https:\/\/doi.org\/10.1111\/j.1600-6143.2006.01540.x.","journal-title":"Am J Transpl"},{"key":"2281_CR20","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00467-007-0582-3","volume":"24","author":"VR Dharnidharka","year":"2009","unstructured":"Dharnidharka VR, Araya CE. Post-transplant lymphoproliferative disease. Pediatr Nephrol. 2009;24:731\u20136. https:\/\/doi.org\/10.1007\/s00467-007-0582-3.","journal-title":"Pediatr Nephrol"},{"key":"2281_CR21","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1053\/j.gastro.2011.02.047","volume":"140","author":"TT MacDonald","year":"2011","unstructured":"MacDonald TT, Monteleone I, Fantini MC, Monteleone G. Regulation of homeostasis and inflammation in the intestine. Gastroenterology. 2011;140:1768\u201375. https:\/\/doi.org\/10.1053\/j.gastro.2011.02.047.","journal-title":"Gastroenterology"},{"issue":"8","key":"2281_CR22","doi-asserted-by":"publisher","first-page":"268","DOI":"10.5500\/wjt.v12.i8.268","volume":"12","author":"W Reiche","year":"2022","unstructured":"Reiche W, Tauseef A, Sabri A, Mirza M, Cantu D, Silberstein P, et al. Gastrointestinal manifestations, risk factors, and management in patients with post-transplant lymphoproliferative disorder: A systematic review. World J Transpl. 2022;12(8):268\u201380.","journal-title":"World J Transpl"},{"key":"2281_CR23","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/bjh.17421","volume":"193","author":"N Shah","year":"2021","unstructured":"Shah N, Eyre TA, Tucker D, Kassam S, Parmar J, Featherstone C, et al. Front-line management of post-transplantation lymphoproliferative disorder in adult solid organ recipient patients - A British society for haematology guideline. Br J Haematol. 2021;193:727\u201340. https:\/\/doi.org\/10.1111\/bjh.17421.","journal-title":"Br J Haematol"},{"key":"2281_CR24","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1111\/j.1600-6143.2005.01098.x","volume":"5","author":"SH Oertel","year":"2005","unstructured":"Oertel SH, Verschuuren E, Reinke P, Zeidler K, Papp-V\u00e1ry M, Babel N, et al. Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD). Am J Transpl. 2005;5:2901\u20136. https:\/\/doi.org\/10.1111\/j.1600-6143.2005.01098.x.","journal-title":"Am J Transpl"},{"key":"2281_CR25","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1182\/blood-2005-01-0377","volume":"107","author":"S Choquet","year":"2006","unstructured":"Choquet S, Leblond V, Herbrecht R, Soci\u00e9 G, Stoppa AM, Vandenberghe P, et al. Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. Blood. 2006;107:3053\u20137. https:\/\/doi.org\/10.1182\/blood-2005-01-0377.","journal-title":"Blood"},{"key":"2281_CR26","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.3324\/haematol.11360","volume":"92","author":"E Gonzalez-Barca","year":"2007","unstructured":"Gonzalez-Barca E, Domingo-Domenech E, Capote FJ, G\u00f3mez-Codina J, Salar A, Bailen A, et al. Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease. Haematologica. 2007;92:1489\u201394. https:\/\/doi.org\/10.3324\/haematol.11360.","journal-title":"Haematologica"},{"key":"2281_CR27","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S1470-2045(11)70300-X","volume":"13","author":"R Trappe","year":"2012","unstructured":"Trappe R, Oertel S, Leblond V, Mollee P, Sender M, Reinke P, et al. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. Lancet Oncol. 2012;13:196\u2013206. https:\/\/doi.org\/10.1016\/S1470-2045(11)70300-X.","journal-title":"Lancet Oncol"},{"key":"2281_CR28","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1200\/JCO.2016.69.3564","volume":"35","author":"RU Trappe","year":"2017","unstructured":"Trappe RU, Dierickx D, Zimmermann H, Morschhauser F, Mollee P, Zaucha JM, et al. Response to rituximab induction is a predictive marker in B-Cell Post-Transplant lymphoproliferative disorder and allows successful stratification into rituximab or R-CHOP consolidation in an International, Prospective, multicenter phase II trial. J Clin Oncol. 2017;35:536\u201343. https:\/\/doi.org\/10.1200\/JCO.2016.69.3564.","journal-title":"J Clin Oncol"},{"key":"2281_CR29","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1038\/s41375-022-01667-1","volume":"36","author":"H Zimmermann","year":"2022","unstructured":"Zimmermann H, Koenecke C, Dreyling MH, Pott C, D\u00fchrsen U, Hahn D, et al. Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial. Leukemia. 2022;36:2468\u201378. https:\/\/doi.org\/10.1038\/s41375-022-01667-1.","journal-title":"Leukemia"},{"key":"2281_CR30","doi-asserted-by":"publisher","first-page":"e13652","DOI":"10.1111\/ctr.13652","volume":"33","author":"UD Allen","year":"2019","unstructured":"Allen UD, Preiksaitis JK, Practice ASTIDC. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: guidelines from the American society of transplantation infectious diseases community of practice. Clin Transpl. 2019;33:e13652. https:\/\/doi.org\/10.1111\/ctr.13652.","journal-title":"Clin Transpl"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-026-02281-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-026-02281-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-026-02281-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T11:25:01Z","timestamp":1775215501000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-026-02281-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2281"],"URL":"https:\/\/doi.org\/10.1007\/s12328-026-02281-9","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from the patient for the publication of this report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}